Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Recent advances have resulted in highly effective "tissue-agnostic" drugs that treat cancers based on their molecular markers ...

Major Factors Driving the Growth of Anticancer Drugs Market: The anticancer drugs market is experiencing robust growth fueled by rising cancer incidence, expanding treatment options, and technological ...

The FDA has approved darolutamide without chemotherapy for treatment of metastatic hormone-sensitive prostate cancer.The FDA ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

An "AI scientist," working in collaboration with human scientists, has found that combinations of cheap and safe drugs—used ...

Innovent Biologics updates results of IBI343 from phase 1 clinical study in patients with advanced pancreatic cancer: San Francisco Wednesday, June 4, 2025, 14:00 Hrs [IST] Innove ...

Lung cancer patients can expect improved long term survival under a new treatment combination, according to new Irish ...

Market analysts believe the real effects of these tax changes on the capital market will become clearer over time ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Amgen AMGN announced encouraging new data from its interim analysis of the global late-stage study evaluating Imdelltra ...